South Korea Biologics Market PPT 2024: Size, Growth, Demand and Forecast till 2032
                     South Korea Biologics 
Market Research and 
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
A c c o r d i n g  t o  t h e  l a t e s t  r e p o r t  b y  I M A R C  G r o u p ,  t i t l e d  " S o u t h  K o r e a  B i o l o g i c s  M a r k e t :  
I n d u s t r y  T r e n d s ,  S h a r e ,  S i z e ,  G r o w t h ,  O p p o r t u n i t y  a n d  F o r e c a s t  2 0 2 4 - 2 0 3 2 , "  t h e  S o u t h  
K o r e a  b i o l o g i c s  m a r k e t  s i z e  i s  p r o j e c t e d  t o  e x h i b i t  a  g r o w t h  r a t e  ( C A G R )  o f  7 . 0 6 %  d u r i n g  
2 0 2 4 - 2 0 3 2 .
T h e  S o u t h  K o r e a  b i o l o g i c s  m a r k e t  i s  e x p e r i e n c i n g  s i g n i f i c a n t  g r o w t h ,  p r i m a r i l y  d r i v e n  b y  t h e  
Report c o u n t r y ' s  r i s i n g  f o c u s  o n  b i o t e c h n o l o g y  a n d  p h a r m a c e u t i c a l  i n n o v a t i o n .  I n  a d d i t i o n  t o  t h i s ,  t h e  
g r o w i n g  i n v e s t m e n t  i n  r e s e a r c h  a n d  d e v e l o p m e n t ,  s t a t e - o f - t h e - a r t  m a n u f a c t u r i n g  f a c i l i t i e s ,  
a n d  a  f a v o r a b l e  r e g u l a t o r y  e n v i r o n m e n t  t h a t  e n c o u r a g e s  i n n o v a t i o n  a n d  s p e e d s  u p  t h e  
Highlight and c o m m e r c i a l i z a t i o n  o f  n e w  t h e r a p i e s  a r e  f u r t h e r  a u g m e n t i n g  t h e  m a r k e t  g r o w t h .  
M o r e o v e r ,  t h e  l a u n c h  o f  n u m e r o u s  i n i t i a t i v e s  b y  t h e  g o v e r n m e n t ,  s u c h  a s  t h e  B i o H e a l t h  2 1  
I n i t i a t i v e ,  a i m e d  a t  p r o m o t i n g  t h e  b i o p h a r m a c e u t i c a l  s e c t o r  a s  a  k e y  f a c t o r  o f  t h e  c o u n t r y ' s  
Description f u t u r e  e c o n o m i c  d e v e l o p m e n t ,  i s  c r e a t i n g  a  p o s i t i v e  o u t l o o k  f o r  t h e  m a r k e t .  B e s i d e s  t h i s ,  t h e  
g r o w i n g  a c c e p t a n c e  o f  a n  e c o s y s t e m  t h a t  i n c l u d e s  b o t h  e s t a b l i s h e d  p h a r m a c e u t i c a l  g i a n t s  a n d  
e m e r g i n g  b i o t e c h  f i r m s ,  e n c o u r a g i n g  a  c o m p e t i t i v e  a n d  d y n a m i c  e n v i r o n m e n t  f o r  t h e  
d e v e l o p m e n t  o f  n o v e l  b i o l o g i c  d r u g s ,  i s  a l s o  s t i m u l a t i n g  t h e  m a r k e t  g r o w t h .
R e q u e s t  f o r  a  P D F  s a m p l e  o f  t h i s  r e p o r t :  
h t t p s : / / w w w . i m a r c g r o u p . c o m / s o u t h - k o r e a - b i o l o g i c s - m a r k e t / r e q u e s t s a m p l e
Report Description
South Korea Biologics Market  Trends:
Fur thermore,  the increas ing demand for  b io log ics  in  South Korea due to  an ag ing populat ion and the 
esca la t ing preva lence of  chron ic  d isorders ,  such as cancer ,  d iabetes,  and auto immune d isorders ,  which 
requi re  advanced therapeut ic  in tervent ions,  is  ac t ing as another  s ign i f icant  growth- induc ing fac tor .  Apar t  
f rom th is ,  the r is ing preference for  b io log ics  over  t rad i t iona l  pharmaceut ica ls  owing to  the i r  ab i l i ty  to  target  
speci f ic  d isease mechanisms wi th  fewer  s ide ef fec ts ,  is  a lso cont r ibut ing to  the market  growth.  
Addi t iona l ly ,  the increas ing par tnersh ips  and co l laborat ions between South Korea and g lobal  
b iopharmaceut ica l  companies,  enhanc ing  i ts  capabi l i t ies in  b io log ics R&D,  are creat ing a pos i t ive out look 
for  the market .  Moreover ,  con t inuous innovat ion,  an ef fec t ive p ipe l ine of  b io log ic  drugs,  and e levat ing 
government  suppor t ,  are  pro jec ted to  propel  the South Korea b io log ics  market  over  the forecasted per iod.
View Report  TOC,  F igures and Tables :  ht tps: / /www.imarcgroup.com/south-korea-bio logics-market
Source Insights:
• Microbial
• Mammalian
• Others
 
Product Insights:
• Monoclonal  Ant ibodies
Report • Vaccines
Segmentation • Recombinant  Proteins
• Antisense,  RNAi and Molecular  Therapy
• Others
Disease Insights:
• Oncology
• Immunological  Disorders
• Cardiovascular  Disorders
• Hematological  Disorders
• Others
Manufacturing Insights:
• Outsourced
• In-House
Report 
Segmentation Regional Insights:
• Seoul Capital  Area
• Yeongnam (Southeastern Region)
• Honam (Southwestern Region)
• Hoseo (Central  Region)
• Others
How has the South Korea biologics market 
performed so far and how will it perform in the 
coming years?
What has been the impact of COVID-19 on the 
South Korea biologics market?
Key 
Questions What is the breakup of the South Korea biologics market on the basis of source?
Answered in 
What is the breakup of the South Korea biologics 
the Report market on the basis of product?
What is the breakup of the South Korea biologics 
market on the basis of disease?
What is the breakup of the South Korea biologics 
market on the basis of manufacturing?
What are the various stages in the value chain of 
the South Korea biologics market?
What are the key driving factors and challenges in 
the South Korea biologics?
Key 
Questions What is the structure of the South Korea biologics market and who are the key players?
Answered in 
the Report What is the degree of competition in the South Korea biologics market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h
    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4    S o u t h  K o r e a  B i o l o g i c s  M a r k e t  -  I n t r o d u c t i o n
Contents     4 . 1     O v e r v i e w    4 . 2     M a r k e t  D y n a m i c s
    4 . 3     I n d u s t r y  T r e n d s
    4 . 4     C o m p e t i t i v e  I n t e l l i g e n c e
5    S o u t h  K o r e a  B i o l o g i c s  M a r k e t  L a n d s c a p e
    5 . 1     H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
    5 . 2     M a r k e t  F o r e c a s t  (  2 0 2 4 - 2 0 3 2 )
6    S o u t h  K o r e a  B i o l o g i c s  M a r k e t  -  B r e a k u p  b y  S o u r c e
    6 . 1     M i c r o b i a l
        6 . 1 . 1  O v e r v i e w
        6 . 1 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 1 . 3  M a r k e t  F o r e c a s t  (  2 0 2 4 - 2 0 3 2 )
    6 . 2     M a m m a l i a n
        6 . 2 . 1  O v e r v i e w
        6 . 2 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 2 . 3  M a r k e t  F o r e c a s t  (  2 0 2 4 - 2 0 3 2 )
       
    6 . 3     O t h e r s
        6 . 3 . 1  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 3 . 2  M a r k e t  F o r e c a s t  (  2 0 2 4 - 2 0 3 2 )
7    S o u t h  K o r e a  B i o l o g i c s  M a r k e t  -  B r e a k u p  b y  P r o d u c t
    7 . 1     M o n o c l o n a l  A n t i b o d i e s
        7 . 1 . 1  O v e r v i e w
        7 . 1 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        7 . 1 . 3  M a r k e t  F o r e c a s t  (  2 0 2 4 - 2 0 3 2 )
    7 . 2     V a c c i n e s
        7 . 2 . 1  O v e r v i e w
        7 . 2 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
Table of         7 . 2 . 3  M a r k e t  F o r e c a s t  (  2 0 2 4 - 2 0 3 2 )
    7 . 3     R e c o m b i n a n t  P r o t e i n s
        7 . 3 . 1  O v e r v i e w
Contents         7 . 3 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )        7 . 3 . 3  M a r k e t  F o r e c a s t  (  2 0 2 4 - 2 0 3 2 )
    7 . 4     A n t i s e n s e ,  R N A i  a n d  M o l e c u l a r  T h e r a p y
        7 . 4 . 1  O v e r v i e w
        7 . 4 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        7 . 4 . 3  M a r k e t  F o r e c a s t  (  2 0 2 4 - 2 0 3 2 )
    7 . 5     O t h e r s
        7 . 5 . 1  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        7 . 5 . 2  M a r k e t  F o r e c a s t  (  2 0 2 4 - 2 0 3 2 )
8    S o u t h  K o r e a  B i o l o g i c s  M a r k e t  -  B r e a k u p  b y  D i s e a s e
    8 . 1     O n c o l o g y
        8 . 1 . 1  O v e r v i e w
        8 . 1 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        8 . 1 . 3  M a r k e t  F o r e c a s t  (  2 0 2 4 - 2 0 3 2 )     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht t ps : / /w ww. i ma rc gro up . c o m /s o u t h -ko rea -b i o l o g i c s -ma rke t / t o
c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: